Overview
Paige (Paige.ai) is a pioneer in computational pathology, recognized for delivering the first FDA-cleared AI for prostate cancer. By 2026, the platform has evolved into a comprehensive oncology intelligence suite powered by Virchow, one of the world's largest AI foundation models for life sciences. Technically, Paige leverages multi-scale vision transformers (ViT) and deep learning algorithms trained on millions of multi-gigapixel whole-slide images (WSI). Its architecture is designed to integrate directly into the pathologist's workflow, providing real-time diagnostic support, automated grading, and biomarker quantification. The platform operates within a secure, cloud-native environment or hybrid on-premise setups, ensuring high-speed rendering of massive image files via the FullFocus viewer. Market-wise, Paige serves as the central nervous system for digital labs, bridging the gap between morphology and molecular pathology to enable precision medicine at scale. Its 2026 position is defined by its ability to not only detect cancer but to predict therapy response and clinical outcomes through AI-driven biomarker analysis.